If this message is not displayed properly, click here please. |
|
|
|
AWARD-WINNING HUMAN MEDICINE |
|
|
Dear Ladies and Gentlemen
Our network keeps growing – thanks to people like you. Every year, new faces join us, and at the same time we remain closely connected with everyone who has long been part of the Jung family. Research thrives on exchange: learning from one another, encouraging each other, and making ideas bigger together. That’s why we create spaces for encounter – face to face at our events and in digital formats. We’re glad you’re with us. Be inspired by the stories in this newsletter – and feel free to share your thoughts or feedback.
|
|
JUNG FELLOWS: FIRST AWARD FOR MEDICAL HISTORY
At this year’s network meeting, the 2025 Jung Fellows gathered at the foundation: Johannes Spengler, Lena Polensky, Nico Rademann, Alina Klein, and Tobias Bokowski (from left). For the first time, the Jung Fellowship for Medical History was awarded – this year to Maria Krümpelmann (right). The focus was on personal connections: alumni Fellows (above) also joined and shared their experience. The meeting is establishing itself as a firm date in our calendar and creates room for collaboration and new ideas.
|
|
|
BLANKENESE CONFERENCE 2025: SCIENCE IN DIALOGUE
For the second year in a row we supported the Blankenese Conferences, strengthening exchange and networking across disciplines. Since 1979, the conferences have brought cutting-edge research to Hamburg. Our Chairman of the Board of Trustees, Jochen Spethmann, delivered a welcome at the opening. Highlights included the Jung Lectures by Prof. Ivan Đikić (Jung Prize 2013) and Prof. Stefan Rose-John (Jung Medal 2023), who presented their latest research. Learn more. |
|
|
TREAT FASTER, HEAL BETTER
The Jung Foundation is supporting Doctors Without Boders/ Médecins Sans Frontières (MSF) with €300,000 to implement the „endTB-Q“ study. The study aims at evaluating a personalised, shorter therapy for drug-resistant tuberculosis. New results show high success rates.
Project Director and Principal Investigator Lorenzo Guglielmetti has been named to the “TIME100 Health 2025.” Learn more.
|
|
|
CONNECTING RESEARCH AND REMEMBRANCE
From responsibility to action: following the study we initiated on our founder, we are funding a research project at the Neuengamme Concentration Camp Memorial. With €477,000, the camp informary in being researched as a key to understanding violence, exploitation, and survival in the camp; findings will flow into a new permanent exhibition. Background and next steps at a glance. |
|
|
SUCCESSES OF JUNG LAUREATES |
|
FISCHER, ROSE-JOHN & BAUMEISTER: HONOURS FOR JUNG MEDAL RECIPIENTS
Prof. Alain Fischer (Jung Medal 2022) received the Fondation pour la Recherche Médicale’s 2024 Prix Jean Bernard for pioneering gene therapy and exemplary science communication.
Prof. Stefan Rose-John (Jung Medal 2023) was honoured with the 2024 ICIS-BioLegend William E. Paul Award for fundamental contributions to IL-6 biology.
Prof. Wolfgang Baumeister (Jung Medal 2018) will receive the 2025 Shaw Prize for cryo-electron tomography
|
|
|
TSCHÖP, MOSER & ĐIKIĆ: NEW ACHIEVEMENTS BY JUNG PRIZE WINNERS
Prof. Matthias Tschöp (Jung Prize 2021) received the Hector Science Award and was elected the next President of LMU Munich.
Prof. Tobias Moser (Jung Prize 2017) presented “ChReef,” an improved optogenetic light switch that activates cells with very little light.
Prof. Ivan Đikić (Jung Prize 2013) was awarded a LOEWE Distinguished Professorship for his ProxiDrugs research at Goethe University Frankfurt.
|
|
|
RUF & FRIEDRICH: CAREER DEVELOPMENT AWARDEES MAKE THEIR MARK
Dr Benjamin Ruf (Jung Career Advancement Award 2025) is leveraging rare MAIT cells as a Clinician Scientist at the M3 Centre in Tübingen to improve immunotherapies against liver cancer – recognized with the Württemberg Cancer Prize.
Dr Maximilian U. Friedrich (Jung Career Advancement Award 2024) develops AI-based smartphone video analysis to measure Parkinson’s motor symptoms more precisely; he received the NeuroTech Innovation Prize.
|
|
|
50 YEARS OF THE JUNG PRIZE
In 2026, we will celebrate “50 Years of the Jung Prize for Medicine.” With an endowment of €300,000, the Jung Prize is among the most highly endowed medical awards in Europe. Since its inception in 1976, the award has honored researchers whose work shapes the progress of human medicine and paves the way for new therapeutic approaches. Three former laureates went on to receive the Nobel Prize: Emmanuelle Charpentier (2015), Harald zur Hausen (2008), and Rolf Martin Zinkernagel (1996).
|
|
|
SYMPOSIA 2026
Next year we’re again creating and supporting platforms like the Jung Symposium and the Blankenese Conferences to foster exchange with outstanding scientists—online and in person. If you’d like to join us, please save these dates:
👉 Jung Symposium “Outstanding Human Medicine 2026”: Wednesday, 20 May 2026
👉 Blankenese Conferences 2026: Sunday, 31 May - Wednesday, 3 June 2026
|
|
|
CONTACT Questions or ideas—or would you like to support our work? We look forward to hearing from you!
+49 40 880 80 51
info@jung-stiftung.de |
|
|
|
|
Jung-Stiftung für Wissenschaft und Forschung
Management Verena Strasoldo
Elbchaussee 215
22605 Hamburg
+49 40 880 80 51
info@jung-stiftung.de |
|
|
If you don't want to receive any more messages (to: valeria.biebrach@muthkomm.de), you can unsubscribe here free of charge at any time. |
|
|
|
|
